Jackson Lisa A, Yu Onchee, Belongia Edward A, Hambidge Simon J, Nelson Jennifer, Baxter Roger, Naleway Allison, Gay Charlene, Nordin James, Baggs James, Iskander John
Group Health Research Institute, Seattle WA, USA.
BMC Infect Dis. 2009 Oct 5;9:165. doi: 10.1186/1471-2334-9-165.
Local reactions are the most commonly reported adverse events following tetanus and diphtheria toxoid (Td) vaccine and the risk of local reactions may increase with number of prior Td vaccinations.
To estimate the risk of medically attended local reactions following Td vaccination in adolescents and young adults we conducted a six-year retrospective cohort study assessing 436,828 Td vaccinations given to persons 9 through 25 years of age in the Vaccine Safety Datalink population from 1999 through 2004.
Overall, the estimated risk of a medically attended local reaction was 3.6 events per 10,000 Td vaccinations. The lowest risk (2.8 events per 10,000 vaccinations) was found in the 11 to 15 year old age group. In comparison with that group, the event risks were significantly higher in both the 9 to 10 and 21 to 25 year old age groups. The risk of a local reaction was significantly higher in persons who had received another tetanus and diphtheria toxoid containing vaccine (TDCV) in the previous five years (incidence rate ratio, 2.9; 95% confidence interval, 1.2 to 7.2). Twenty-eight percent of persons with a local reaction to Td vaccine were prescribed antibiotics.
Medically attended local reactions were uncommon following Td vaccination. The risk of those reactions varied by age and by prior receipt of TDCVs. These findings provide a point of reference for future evaluations of the safety profile of newer vaccines containing tetanus or diphtheria toxoid.
局部反应是破伤风和白喉类毒素(Td)疫苗接种后最常报告的不良事件,并且局部反应的风险可能会随着既往接种Td疫苗的次数增加而升高。
为了评估青少年和年轻成年人接种Td疫苗后出现需要就医的局部反应的风险,我们开展了一项为期六年的回顾性队列研究,评估了1999年至2004年疫苗安全数据链人群中9至25岁人群接种的436,828剂Td疫苗。
总体而言,估计每10,000剂Td疫苗接种出现需要就医的局部反应的风险为3.6例。在11至15岁年龄组中发现风险最低(每10,000剂接种2.8例)。与该组相比,9至10岁和21至25岁年龄组的事件风险显著更高。在过去五年中接种过另一剂含破伤风和白喉类毒素疫苗(TDCV)的人群中,局部反应的风险显著更高(发病率比,2.9;95%置信区间,1.2至7.2)。28%对Td疫苗有局部反应的人被开具了抗生素。
接种Td疫苗后出现需要就医的局部反应并不常见。这些反应的风险因年龄和既往是否接种TDCV而异。这些发现为未来评估含破伤风或白喉类毒素的新型疫苗的安全性概况提供了一个参考点。